LncRNA PTENP1 inhibits cervical cancer progression by suppressing miR-106b

References

• Chauhan SR, Bharadwaj M. Gearing up T-cell immunotherapy in cervical cancer. Curr Probl Cancer. 2018;42(2):175–188.
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.
   PubMed Web of Science ®Google Scholar
• Shrestha AD, Neupane D, Vedsted P, et al. Cervical cancer prevalence, incidence and mortality in low and middle income countries: a systematic review. Asian Pac J Cancer Prev. 2018;19(2):319–324.
   PubMedGoogle Scholar
• Ouh YT, Lee JK. Proposal for cervical cancer screening in the era of HPV vaccination. Obstet Gynecol Sci. 2018;61(3):298–308.
   PubMedGoogle Scholar
• Vaccarella S, Franceschi S, Engholm G, et al. 50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidence. Br J Cancer. 2014;111(5):965–969.
   PubMed Web of Science ®Google Scholar
• Vaccarella S, Franceschi S, Zaridze D, et al. Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017-40: a population-based study. Lancet Oncol. 2016;17(10):1445–1452.
   PubMed Web of Science ®Google Scholar
• Kimmig R, Ind T. Minimally invasive surgery for cervical cancer: consequences for treatment after LACC Study. J Gynecol Oncol. 2018;29(4):e75.
   PubMed Web of Science ®Google Scholar
• Chiu HS, Somvanshi S, Patel E, et al. Pan-cancer analysis of lncRNA regulation supports their targeting of cancer genes in each tumor context. Cell Rep. 2018;23(1):297–312.
   PubMed Web of Science ®Google Scholar
• Zhang R, Guo Y, Ma Z, et al. Long non-coding RNA PTENP1 functions as a ceRNA to modulate PTEN level by decoying miR-106b and miR-93 in gastric cancer. Oncotarget. 2017;8(16):26079–26089.
   PubMedGoogle Scholar
• Kotake Y, Nakagawa T, Kitagawa K, et al. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene. 2011;30(16):1956–1962.
   PubMed Web of Science ®Google Scholar
• Poliseno L, Salmena L, Zhang J, et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature. 2010;465(7301):1033–1038.
   PubMed Web of Science ®Google Scholar
• Guo X, Deng L, Deng K, et al. Pseudogene PTENP1 suppresses gastric cancer progression by modulating PTEN. ACAMC. 2016;16(4):456–464.
   Google Scholar
• Kovalenko TF, Morozova KV, Ozolinya LA, et al. The PTENP1 pseudogene, unlike the PTEN gene, is methylated in normal endometrium, as well as in endometrial hyperplasias and carcinomas in middle-aged and elderly females. Acta Naturae. 2018;10(1):43–50.
   PubMed Web of Science ®Google Scholar
• Yu G, Yao W, Gumireddy K, et al. Pseudogene PTENP1 functions as a competing endogenous RNA to suppress clear-cell renal cell carcinoma progression. Mol Cancer Ther. 2014;13(12):3086–3097.
   PubMed Web of Science ®Google Scholar
• Kapodistrias N, Bobori C, Theocharopoulou G. MiR-140-3p downregulation in association with PDL-1 overexpression in many cancers: a review from the literature using predictive bioinformatics tools. Adv Exp Med Biol. 2017;988:225–233.
   PubMed Web of Science ®Google Scholar
• Liu Y, Ding Y, Huang J, et al. MiR-141 suppresses the migration and invasion of HCC cells by targeting Tiam1. PLoS One. 2014;9(2):e88393.
   PubMed Web of Science ®Google Scholar
• Zhang J, Chen D, Liang S, et al. miR-106b promotes cell invasion and metastasis via PTEN mediated EMT in ESCC. Oncol Lett. 2018;15(4):4619–4626.
   PubMed Web of Science ®Google Scholar
• Karreth FA, Tay Y, Perna D, et al. In vivo identification of tumor-suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. Cell. 2011;147(2):382–395.
   PubMed Web of Science ®Google Scholar
• Tay Y, Kats L, Salmena L, et al. Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell. 2011;147(2):344–357.
   PubMed Web of Science ®Google Scholar
• Chen CL, Tseng YW, Wu JC, et al. Suppression of hepatocellular carcinoma by baculovirus-mediated expression of long non-coding RNA PTENP1 and microRNA regulation. Biomaterials. 2015;44:71–81.
   PubMed Web of Science ®Google Scholar
• Khuu C, Utheim TP, Sehic A. The three paralogous microRNA clusters in development and disease, miR-17-92, miR-106a-363, and miR-106b-25. Scientifica (Cairo). 2016;2016:1379643–1379610.
   PubMed Web of Science ®Google Scholar
• Kim BH, Hong SW, Kim A, et al. Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma. J Surg Oncol. 2013;107(5):505–510.
   PubMed Web of Science ®Google Scholar
• Yau WL, Lam CS, Ng L, et al. Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition process. PLoS One. 2013;8(3):e57882.
   PubMed Web of Science ®Google Scholar
• Petrocca F, Vecchione A, Croce CM. Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res. 2008;68(20):8191–8194.
   PubMed Web of Science ®Google Scholar
• Poliseno L, Salmena L, Riccardi L, et al. Identification of the miR-106b∼25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci Signal. 2010;3(117):ra29–ra29.
   PubMed Web of Science ®Google Scholar
• Qian YY, Li K, Liu QY, et al. Long non-coding RNA PTENP1 interacts with miR-193a-3p to suppress cell migration and invasion through the PTEN pathway in hepatocellular carcinoma. Oncotarget. 2017;8(64):107859–107869.
   PubMedGoogle Scholar
• Ivanovska I, Ball AS, Diaz RL, et al. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol Cell Biol. 2008;28(7):2167–2174. Cleary MA,
   PubMed Web of Science ®Google Scholar
• Yu M, Trobridge P, Wang Y, et al. Inactivation of TGF-beta signaling and loss of PTEN cooperate to induce colon cancer in vivo. Oncogene. 2014;33(12):1538–1547.
   PubMed Web of Science ®Google Scholar
• Xu Z, Zheng G, Wang Y, et al. Aqueous Huaier extract suppresses gastric cancer metastasis and epithelial to mesenchymal transition by targeting twist. J Cancer. 2017;8(18):3876–3886.
   PubMed Web of Science ®Google Scholar
• Pal M, Bhattacharya S, Kalyan G, et al. Cadherin profiling for therapeutic interventions in epithelial mesenchymal transition (EMT) and tumorigenesis. Exp Cell Res. 2018;368(2):137–146.
   PubMed Web of Science ®Google Scholar
• Mulholland DJ, Kobayashi N, Ruscetti M, et al. Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells. Cancer Res. 2012;72(7):1878–1889.
   PubMed Web of Science ®Google Scholar